Welcome to our dedicated page for Caci Intl SEC filings (Ticker: CACI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
CACI International Inc filings document the formal disclosures of an operating national security technology company serving U.S. government defense, intelligence and federal civilian customers. Recent Form 8-K reports cover fiscal-quarter results, financial-condition disclosures, material agreements and exhibits tied to the company's operating performance and contract-driven business.
The filing record also documents capital-structure actions, including unsecured senior notes due 2033, related subsidiary guarantees and financing arrangements connected to the completed ARKA Group acquisition. Other disclosures address accounts receivable purchase arrangements, board composition, director independence, compensatory arrangements and other governance matters reported under current-report requirements.
CACI International Inc. director William L. Jews reported a grant of 338 restricted stock units (RSUs) on October 16, 2025. The RSUs vest as follows: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Following the grant, 338 RSUs were reported as directly owned.
CACI International (CACI) reported an insider equity award. Director Debora A. Plunkett filed a Form 4 showing an acquisition of 338 Restricted Stock Units (RSUs) on October 16, 2025. The RSUs are scheduled to vest as follows: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Following the reported transaction, the filing lists 338 derivative securities beneficially owned with direct (D) ownership.
CACI International (CACI) director Susan M. Gordon reported an equity award on Form 4: a grant of 338 restricted stock units on October 16, 2025.
The RSUs vest in four tranches: 84 shares on January 14, 2026; 84 shares on April 14, 2026; 85 shares on July 13, 2026; and 85 shares on October 11, 2026. Following the grant, 338 derivative securities were beneficially owned, held directly.
CACI International Inc. reported a Form 4 showing Director Philip O. Nolan was granted 338 Restricted Stock Units (RSUs) on October 16, 2025 (transaction code A). The RSUs vest in four tranches during 2026: 84 on January 14, 84 on April 14, 85 on July 13, and 85 on October 11. Following the reported transaction, 338 derivative securities were beneficially owned, with ownership listed as Direct.
CACI International Inc. (CACI) reported a Form 4 for Director and Chair of the Board Lisa Disbrow. On October 16, 2025, she was granted 53 shares of CACI common stock as part of her annual retainer and 492 Restricted Stock Units (RSUs).
The RSUs vest in four equal tranches of 123 shares on January 14, 2026, April 14, 2026, July 13, 2026, and October 11, 2026. Following the grant, she beneficially owned 1,987 CACI shares directly, and 492 RSUs as derivative securities.
CACI International Inc. (CACI) director Stanton D. Sloane reported an equity award on a Form 4. On October 16, 2025, he acquired 338 Restricted Stock Units (RSUs), listed as derivative securities tied to CACI common stock.
The RSUs vest in four installments during 2026: 84 shares on January 14, 84 shares on April 14, 85 shares on July 13, and 85 shares on October 11. Following this grant, the filing shows 338 derivative securities beneficially owned, held directly.
This is a routine director compensation grant disclosed under Section 16, with a defined vesting schedule that spreads delivery over the 2026 calendar year.
CACI International Inc. disclosed a Form 4 showing Director Charles L. Szews received 338 Restricted Stock Units (RSUs) on October 16, 2025.
The award vests in four installments during 2026: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. The filing lists the RSUs in Table II as acquired and directly owned, with 338 derivative securities beneficially owned following the transaction.
This is a routine equity compensation grant to a director and does not indicate cash proceeds to the company.
CACI International (CACI) reported an insider equity award. Director Ryan D. McCarthy received 338 Restricted Stock Units on October 16, 2025. These RSUs convert into shares of CACI common stock as they vest: 84 on January 14, 2026; 84 on April 14, 2026; 85 on July 13, 2026; and 85 on October 11, 2026.
The filing shows the grant as an acquisition of derivative securities with direct ownership. RSUs typically represent a form of equity compensation that settles in stock upon vesting, aligning directors’ interests with long-term shareholder value.
CACI International Inc. (CACI) reported an insider transaction on a Form 4. Director Philip O. Nolan acquired 83 shares of CACI common stock on 10/12/2025 via settlement of restricted stock units, noted with transaction code M. After this transaction, he beneficially owned 2,069 shares directly. These RSUs were part of a 331‑unit grant from 10/17/2024 with scheduled vesting of 82 shares on 1/15/2025, 83 shares on 4/15/2025, 83 shares on 7/14/2025, and 83 shares on 10/12/2025.
CACI International (CACI) director Stanton D. Sloane reported the vesting and settlement of 83 Restricted Stock Units on October 12, 2025, resulting in the acquisition of 83 shares of CACI common stock (transaction code M).
Following this transaction, Sloane beneficially owns 859 shares, held directly. The RSUs were part of a 331-unit grant made on October 17, 2024, scheduled to vest in four tranches: 82 shares on January 15, 2025; 83 on April 15, 2025; 83 on July 14, 2025; and 83 on October 12, 2025.